LBJ Gynecologic Oncology Tumor Board - 9/5/2024

---

RSS

Thursday, September 5, 2024, 7:30 AM - 8:30 AM, MD Anderson - Virtual


AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), ANCC - Nursing Contact Hour(s) (1.00 hours), Non-Physician Attendance (1.00 hours)

The LBJ Gynecologic Oncology Tumor Board is a collaborative activity where healthcare professionals specializing in gynecologic cancers come together to discuss complex cases. During the session, learners review patient histories, diagnostic findings, and treatment plans, pooling their collective expertise to formulate comprehensive and personalized approaches. This interactive forum promotes cross-disciplinary and interdisciplinary communication, knowledge sharing, and the integration of diverse perspectives to optimize the care and outcomes for patients facing gynecologic malignancies.

Objective(s): 1 Evaluate diverse diagnostic approaches for gynecologic oncology cases, considering emerging technologies and evidence-based methodologies to enhance diagnostic accuracy. 2 Engage in collaborative discussions on multidisciplinary treatment strategies, fostering effective communication and knowledge sharing within the gynecologic oncology tumor board 3 Apply critical thinking skills in identifying suitable patients for clinical trials, integrating a multidisciplinary approach to optimize individualized care plans for gynecologic oncology patients.
Location: MD Anderson - Virtual
Specialties: Gynecologic Oncology

Faculty Disclosures:
Michelle S Gonzalez, FNP (Nothing to disclose - 10/24/2023)
Kathleen M Schmeler, MD (Nothing to disclose - 07/26/2024)
Download Handout

1. Evaluate diverse diagnostic approaches for gynecologic oncology cases, considering emerging technologies and evidence-based methodologies to enhance diagnostic accuracy.
2. Engage in collaborative discussions on multidisciplinary treatment strategies, fostering effective communication and knowledge sharing within the gynecologic oncology tumor board
3. Apply critical thinking skills in identifying suitable patients for clinical trials, integrating a multidisciplinary approach to optimize individualized care plans for gynecologic oncology patients.

If you are interested in attending this series contact Latasha Blake at [email protected]

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.